Retinal Disease
Oculis Operations S.a.r.l. focuses its clinical research on diabetic macular edema, a sight-threatening retinal condition associated with diabetes and central vision loss.
- Diabetic macular edema
- Retinal oedema
- Macular pathology
The sponsor’s current clinical activity is concentrated in ophthalmology across multiple countries and research sites, with an emphasis on treatment options for retinal fluid accumulation and vision impairment.
Ophthalmic Therapeutics
Its funded studies examine eye drop-based therapy for retinal disease, reflecting interest in non-invasive ophthalmic treatment approaches for patients with macular involvement.
- Topical ocular therapy
- Vision preservation
- Anterior and posterior segment drug delivery
This therapeutic area places the sponsor within clinical development efforts aimed at expanding treatment options in eye care.
Visual Function
The sponsor’s research activity is centered on outcomes relevant to visual acuity, retinal health, and the management of symptoms that affect daily functioning in people with diabetic eye disease.
- Visual acuity
- Central vision
- Retinal thickness
Clinical interest in this domain aligns with treatment goals for preserving and improving sight in patients with chronic retinal complications.
Multinational Clinical Development
Oculis Operations S.a.r.l. is conducting active studies across Europe, North America, and other international sites, supporting research in multicenter ophthalmology.
- Multicenter trials
- International site networks
- Recruiting ophthalmic studies
Its research footprint includes collaboration with numerous clinical sites, indicating sustained involvement in global development for retinal disorders.
